KMID : 1134820170460030298
|
|
Journal of the Korean Society of Food Science and Nutrition 2017 Volume.46 No. 3 p.298 ~ p.305
|
|
Synergistic Inhibition of Aronia melanocarpa and Moringa oleifera Seed Extract on Experimental Atopic Dermatitis
|
|
Ki Hyeon-Hui
Lee Ji-Hyun Moon Kwang-Hyun Lee Jeong-Ho Kim Dae-Geun Jeong Kyung-Ok Im So-Yeon Lee Young-Mi Kim Dae-Ki
|
|
Abstract
|
|
|
Atopic dermatitis is a chronic, relapsing inflammatory skin disease. This study aimed to investigate the therapeutic benefits of Aronia melanocarpa (AM) and Moringa oleifera seed extract (MO) on experimental atopic dermatitis. We examined the effects of AM or MO and their combination on 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis in BALB/c mice as well as tumor necrosis factor (TNF)-¥á and interferon (IFN)-¥ã-stimulated HaCaT keratinocytes. Mice were orally treated with extract during repeated application of DNCB to shaved dorsal skin. Our results show that treatment with AM and MO in combination reduced histological manifestations such as epidermal hyperplasia and inflammatory cell infiltration. Furthermore, it significantly decreased skin thickness and serum immunoglobulin E (IgE) level compared to the AM or MO alone treated group. Combined extract of AM and MO suppressed expression of TNF-¥á/IFN-¥ã-induced T helper 2 (Th2) chemokines such as thymus and activation-regulated chemokine and macrophage-derived chemokine. To sum up, combination of AM and MO suppressed the inflammatory response and serum IgE as an indicator of several allergic diseases in DNCB-induced experimental atopic dermatitis and Th2 chemokine expression in HaCaT cells. This result suggests that combination of AM and MO could be a valuable strategy to improve atopic dermatitis.
|
|
KEYWORD
|
|
Aronia melanocarpa, Moringa oleifera, atopic dermatitis, 2, 4-dinitrochlorobenzene, keratinocytes
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|